Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
According to Prof. Jeffrey Sonnenfeld and co-author Steven Tian, the college and university presidents who attended the Yale ...
Howie and Harlan discuss a breakthrough pain medication, studies on AI-assisted medicine, the explosion of sports gambling, and the health consequences of the shutdown of USAID. Links: A ...
Daniel Weiss ’85, an art historian and the former president and CEO of the Metropolitan Museum of Art, discusses the complexities, joys, and challenges of leading mission-driven organizations.‌ Art is ...
Daniel Weiss ’85, former president and CEO of the Metropolitan Museum of Art, discusses the distinctive joys and challenges of leading mission-driven organizations.‌ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results